BriaCell Therapeutics Corp. (BCTX), a clinical-stage biotechnology company developing novel immunotherapies, has a key clinical trial milestone this year as it advances potential treatments for patients with metastatic breast cancer facing urgent medical needs.
Breast cancer is the most common cancer in women in the United States, with more than 40,000 deaths per year in the United States, according to the latest data from the American Cancer Society.
For comments and feedback contact: editorial@rttnews.com
April 24, 2026 15:15 ET Economics news flow was relatively light this week even as the conflict in the Middle East continued, raising concerns for policymakers. In the U.S., spending data, initial jobless claims and pending home sales were the highlights. Business confidence in the biggest euro area economy was in focus in Europe. Inflation data from Japan gained attention in Asia.